Literature DB >> 22927554

Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials?

Stefan D Anker, John J V McMurray.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22927554     DOI: 10.1093/eurheartj/ehs277

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  20 in total

1.  Home Time as a Patient-Centered Outcome in Administrative Claims Data.

Authors:  Hemin Lee; Sandra M Shi; Dae Hyun Kim
Journal:  J Am Geriatr Soc       Date:  2018-12-21       Impact factor: 5.562

2.  Recurrent events analysis for examination of hospitalizations in heart failure: insights from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) trial.

Authors:  Juarez R Braga; Jack V Tu; Peter C Austin; Rinku Sutradhar; Heather J Ross; Douglas S Lee
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2018-01-01

3.  Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis.

Authors:  Esther Vorovich; Benjamin French; Bonnie Ky; Lee Goldberg; James C Fang; Nancy K Sweitzer; Thomas P Cappola
Journal:  J Card Fail       Date:  2014-06-11       Impact factor: 5.712

4.  Statistical models for composite endpoints of death and non-fatal events: a review.

Authors:  Lu Mao; KyungMann Kim
Journal:  Stat Biopharm Res       Date:  2021-07-06       Impact factor: 1.586

5.  On recurrent-event win ratio.

Authors:  Lu Mao; KyungMann Kim; Yi Li
Journal:  Stat Methods Med Res       Date:  2022-03-29       Impact factor: 2.494

6.  Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints.

Authors:  Geraldine Rauch; Meinhard Kieser; Harald Binder; Antoni Bayes-Genis; Antje Jahn-Eimermacher
Journal:  Clin Res Cardiol       Date:  2018-02-16       Impact factor: 5.460

7.  On restricted mean time in favor of treatment.

Authors:  Lu Mao
Journal:  Biometrics       Date:  2021-09-25       Impact factor: 2.571

8.  Competing risks analyses: objectives and approaches.

Authors:  Marcel Wolbers; Michael T Koller; Vianda S Stel; Beat Schaer; Kitty J Jager; Karen Leffondré; Georg Heinze
Journal:  Eur Heart J       Date:  2014-04-07       Impact factor: 29.983

9.  Time spent outside of the hospital, CKD progression, and mortality: a prospective cohort study.

Authors:  Lin Zhang; Heng-Lan Wu; Hai-Feng Yu; Jun-Liang Zhou
Journal:  Int Urol Nephrol       Date:  2021-01-01       Impact factor: 2.370

10.  Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations.

Authors:  Jeffrey A Bakal; Finlay A McAlister; Wei Liu; Justin A Ezekowitz
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.